# EDGAR Filing Document

**Accession Number:** 0001874097
**File Stem:** 0001213900-25-073134
**Filing Date:** 2025-8
**Character Count:** 166223
**Document Hash:** f0f1fd95222b712a8a13b865f5425ef4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-073134.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001213900-25-073134

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 71

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cyngn Inc.
- **CENTRAL INDEX KEY:** 0001874097
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 462007094
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40932
- **FILM NUMBER:** 251195186

**BUSINESS ADDRESS:**
- **STREET 1:** 1344 TERRA BELLA AVENUE
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043
- **BUSINESS PHONE:** 650-924-5905

**MAIL ADDRESS:**
- **STREET 1:** 1344 TERRA BELLA AVENUE
- **CITY:** MOUNTAIN VIEW
- **STATE:** CA
- **ZIP:** 94043

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cyngn, Inc.
- **DATE OF NAME CHANGE:** 20210721

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 30, 2025**

**or**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _______ to _______**

**Commission file number: 001-40932**

**CYNGN INC.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **46-2007094** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

**1344 Terra Bella Mountain View, CA 94043**

(Address of principal executive offices) (Zip Code)

**(650) 924-5905**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.00001 | CYN | Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 7, 2025, the issuer had 7,039,266 shares of common stock, par value $0.00001 per share, outstanding.

**CYNGN INC.**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  |  | **Page No.** |
| [**PART I** FINANCIAL INFORMATION](#a_001) | [**PART I** FINANCIAL INFORMATION](#a_001) | 1 |
| ITEM 1. | [FINANCIAL STATEMENTS](#a_002) | 1 |
|  | [Condensed Consolidated Balance Sheets as of June 30, 2025 (unaudited) and December 31, 2024](#a_003) | 1 |
|  | [Condensed Consolidated Statements of Operations for the Three and Six Months ended June 30, 2025 and 2024 (unaudited)](#a_004) | 2 |
|  | [Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months ended June 30, 2025 and 2024 (unaudited)](#a_005) | 3 |
|  | [Condensed Consolidated Statements of Cash Flows for the Six Months ended June 30, 2025 and 2024 (unaudited)](#a_006) | 4 |
|  | [Notes to Condensed Consolidated Financial Statements (unaudited)](#a_007) | 5 |
| ITEM 2. | [MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#a_008) | 28 |
| ITEM 3. | [QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#a_009) | 38 |
| ITEM 4. | [CONTROLS AND PROCEDURES](#a_010) | 38 |
| [**PART II** OTHER INFORMATION](#a_011) | [**PART II** OTHER INFORMATION](#a_011) | 40 |
| ITEM 1. | [LEGAL PROCEEDINGS](#a_012) | 40 |
| ITEM 1A. | [RISK FACTORS](#a_013) | 40 |
| ITEM 2. | [UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](#a_014) | 40 |
| ITEM 3. | [DEFAULTS UPON SENIOR SECURITIES](#a_015) | 40 |
| ITEM 4. | [MINE SAFETY DISCLOSURES](#a_016) | 40 |
| ITEM 5. | [OTHER INFORMATION](#a_017) | 40 |
| ITEM 6. | [EXHIBITS](#a_018) | 41 |
| [SIGNATURES](#a_019) | [SIGNATURES](#a_019) | 42 |

---

i

**PART 1 — FINANCIAL INFORMATION**

**ITEM 1. FINANCIAL STATEMENTS**

**CYNGN INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
|  | **(Unaudited)**<br>**June 30,**<br>**2025** |<br>**December 31,**<br>**2024** |
| **ASSETS** |  |  |
| **CURRENT ASSETS** |  |  |
| Cash | $31343213 | $23617733 |
| Short-term investments | 7891623 | – |
| Prepaid expenses and other current assets | 4399798 | 1965222 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL CURRENT ASSETS** | 43634634 | 25582955 |
| Property and equipment, net | 2550764 | 2319402 |
| Right of use asset, net | 6411126 | 297918 |
| Intangible assets, net | 3065806 | 1895074 |
| Security Deposit | 518584 | – |
| &nbsp;&nbsp;&nbsp;**TOTAL ASSETS** | $56180914 | $30095349 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| **CURRENT LIABILITIES** |  |  |
| Accounts payable | $176269 | $297778 |
| Accrued expenses and other current liabilities | 2621405 | 2874216 |
| Current operating lease liability | 202562 | 317344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL CURRENT LIABILITIES** | 3000236 | 3489338 |
| Non-current operating lease liability | 6417520 | – |
| Warrant liability | – | 15012361 |
| &nbsp;&nbsp;&nbsp;**TOTAL LIABILITIES** | 9417756 | 18501699 |
| **Commitments and contingencies (Note 12)** |  |  |
| **STOCKHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;&nbsp;Common stock, Par $0.00001; 400,000,000 and 200,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 7,039,266 and 199,110 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 70 | 2 |
| Additional paid-in capital | 249074145 | 200863551 |
| Accumulated deficit | (202311057) | (189269903) |
| **TOTAL STOCKHOLDERS' EQUITY** | 46763158 | 11593650 |
| **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $56180914 | $30095349 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**CYNGN INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **REVENUE** | $33726 | $8665 | $80878 | $14179 |
| **COSTS AND EXPENSES** |  |  |  |  |
| Cost of revenue | 16944 | 14922 | 28758 | 128698 |
| Research and development | 1970125 | 3199078 | 4077034 | 6353775 |
| General and administrative | 3548522 | 2606869 | 6691984 | 5310269 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL COSTS AND EXPENSES** | 5535591 | 5820869 | 10797776 | 11792742 |
| &nbsp;&nbsp;&nbsp;**LOSS FROM OPERATIONS** | (5501865) | (5812204) | (10716898) | (11778563) |
| **OTHER INCOME (EXPENSE), NET** |  |  |  |  |
| Interest income (expense), net | (197992) | (1669) | (123173) | (342) |
| Change in fair value of warrant liability | ‒ | ‒ | (2544518) | ‒ |
| Other income (expense), net | 251545 | (5079) | 343435 | (10126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL OTHER INCOME (EXPENSE), NET** | 53553 | (6748) | (2324256) | (10468) |
| **NET LOSS** | $(5448312) | $(5818952) | $(13041154) | $(11789031) |
| Net loss per share attributable to common stockholders, basic and diluted | $(2.70) | $(610.85) | $(8.22) | $(1521.56) |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 2017228 | 9526 | 1586453 | 7748 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**CYNGN INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
| <br>**Three Months Ended June 30, 2025** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total Stockholders'**<br>**Equity** |
| Balance as of March 31, 2025 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | 1751906 | $18 | $219005632 | $(196862745) | $22142905 |
| Exercise of stock options and vesting of restricted stock units |  | – | 15 | – | – | – | – |
| Issuance of common stock in connection with the public offering and pre-funded warrants |  | – | 5287345 | 52 | 29611626 | – | 29611678 |
| Stock-based compensation |  | – |  | – | 456887 | – | 456887 |
| Net loss |  | – | – | – | – | (5448312) | (5448312) |
| **Balance as of June 30, 2025** |  | $– | 7039266 | $70 | $249074145 | $(202311057) | $46763158 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
| <br>**Three Months Ended June 30, 2024** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total Stockholders'**<br>**Equity** |
| Balance as of March 31, 2024 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– | 6721 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– | $173958889 | $(165987698) | $7971191 |
| Issuance of at-the-market common stock, net of issuance costs |  | – | 1683 | – | 2365034 | – | 2365034 |
| Exercise of stock options and vesting of restricted stock units |  | – | 7 | – | (597) | – | (597) |
| Issuance of common stock in connection with the public offering |  | – | 1456 | – | 4569902 | – | 4569902 |
| Exercise of pre-funded warrants in connection with the public offering |  | – | 2013 | – | 600 | – | 600 |
| Stock-based compensation |  | – |  | – | 615651 | – | 615651 |
| Net loss |  | – | – | – | – | (5818952) | (5818952) |
| **Balance as of June 30, 2024** |  | $– | 11880 | $– | $181509479 | $(171806650) | $9702829 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
| <br>**Six Months Ended June 30, 2025** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total Stockholders'**<br>**Equity** |
| Balance as of December 31, 2024 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | 199110 | $2 | $200863551 | $(189269903) | $11593650 |
| Exercise of stock options and vesting of restricted stock units |  | – | 15 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– | – | – | – |
| Reclassification of Series A warrants to equity in connection with the public offering |  | – |  | – | 7634428 | – | 7634428 |
| Exercise of Series B warrants in connection with the public offering, net of issuance costs |  | – | 1552796 | 16 | 9971409 | – | 9971425 |
| Issuance of common stock in connection with the public offering |  | – | 5287345 | 52 | 29611626 | – | 29611678 |
| Stock-based compensation |  | – |  | – | 993131 | – | 993131 |
| Net loss |  | – | – | – | – | (13041154) | (13041154) |
| **Balance as of June 30, 2025** |  | $– | 7039266 | $70 | $249074145 | $(202311057) | $46763158 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock** | **Preferred Stock** | **Common Stock** | **Common Stock** | | | |
| <br>**Six Months Ended June 30, 2024** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-in**<br>**Capital** | **Accumulated**<br>**Deficit** | **Total Stockholders'**<br>**Equity** |
| Balance as of December 31, 2023 |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | 5147 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;– | $170652808 | $(160017619) | $10635189 |
| Issuance of at-the-market common stock, net of issuance costs |  | – | 2565 | – | 5017144 | – | 5017144 |
| Exercise of stock options and vesting of restricted stock units |  | – | 8 | – | (597) | – | (597) |
| Issuance of common stock and pre-funded warrants in connection with the public offering |  | – | 1456 | – | 4569901 | – | 4569901 |
| Exercise of pre-funded warrants in connection with the public offering |  | – | 2704 | – | 548 | – | 548 |
| Stock-based compensation |  | – |  | – | 1269675 | – | 1269675 |
| Net loss |  | – | – | – | – | (11789031) | (11789031) |
| **Balance as of June 30, 2024** |  | $– | 11880 | $– | $181509479 | $(171806650) | $9702829 |

---

The accompanying notes are an integral part of these condensed financial statements.

**CYNGN INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** |
|  | **2025** | **2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(13041154) | $(11789031) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 603116 | 455879 |
| &nbsp;&nbsp;&nbsp;Stock-based compensation | 993131 | 1269675 |
| &nbsp;&nbsp;&nbsp;Realized gain on short-term investments | (316324) | (88912) |
| &nbsp;&nbsp;&nbsp;Loss on disposed assets | 10426 |  |
| &nbsp;&nbsp;&nbsp;Patent impairment | – | 118831 |
| &nbsp;&nbsp;&nbsp;Change in fair value of warrant liability | 2544518 | – |
| &nbsp;&nbsp;&nbsp;*Changes in operating assets and liabilities:* |  |  |
| &nbsp;&nbsp;&nbsp;Prepaid expenses, operating lease right-of-use assets, and other assets | (2953162) | (19729) |
| &nbsp;&nbsp;&nbsp;Accounts payable | (71509) | (16788) |
| &nbsp;&nbsp;&nbsp;Accrued expenses, lease liabilities, and other current liabilities | (539405) | (155403) |
| &nbsp;&nbsp;&nbsp;**NET CASH USED IN OPERATING ACTIVITIES** | (12770363) | (10225478) |
| &nbsp;&nbsp;&nbsp;**CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Purchase of property and equipment | (352853) | (577497) |
| &nbsp;&nbsp;&nbsp;Acquisition of intangible asset | (1186659) | (32381) |
| &nbsp;&nbsp;&nbsp;Purchase of short-term investments | (30805799) | (7022292) |
| &nbsp;&nbsp;&nbsp;Proceeds from maturity of short-term investments | 23230501 | 10610000 |
| &nbsp;&nbsp;&nbsp;**NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES** | (9114810) | 2977830 |
| &nbsp;&nbsp;&nbsp;**CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from at-the-market equity financing, net of issuance costs | – | 5017144 |
| &nbsp;&nbsp;&nbsp;Proceeds from public issuance of common stock and pre-funded warrants, net of issuance costs | 29611678 | 4570455 |
| &nbsp;&nbsp;&nbsp;Issuance costs from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants | (1025) | – |
| &nbsp;&nbsp;&nbsp;Issuance costs for stock dividend and restricted stock units | – | (597) |
| &nbsp;&nbsp;&nbsp;**NET CASH PROVIDED BY FINANCING ACTIVITIES** | 29610653 | 9587002 |
| &nbsp;&nbsp;&nbsp;Net increase in cash and cash equivalents and restricted cash | 7725480 | 2339354 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents and restricted cash, beginning of year | 23617733 | 3591623 |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents and restricted cash, end of year | $31343213 | $5930977 |
| &nbsp;&nbsp;&nbsp;**SUPPLEMENTAL DISCLOSURE OF CASH FLOW:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid during the period for interest and taxes | $- | $- |
| &nbsp;&nbsp;&nbsp;**SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition of right-of-use asset in exchange for new operating lease obligation | $6411127 | - |
| &nbsp;&nbsp;&nbsp;Acquisition of property and equipment included in accounts payable and accrued expenses | $- | $132405 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

**CYNGN INC. AND SUBSIDIARIES**

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. Description of Business**

Cyngn Inc., together with its subsidiary (collectively, "Cyngn" or the "Company"), was incorporated in Delaware in 2013. The wholly owned subsidiary is Cyngn Singapore PTE. LTD., a Singaporean limited company organized in 2015. The Company is headquartered in Mountain View, CA.

Cyngn develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Our full-stack autonomous driving software, ("DriveMod"), can be integrated onto vehicles manufactured by Original Equipment Manufacturers ("OEM") either via retrofit of existing vehicles or by integration directly into vehicle assembly. The Enterprise Autonomy Suite ("EAS") is designed to be compatible with sensors and components from leading hardware technology providers and integrate our proprietary Autonomous Vehicle ("AV") software to produce differentiated autonomous vehicles.

The Company has been operating autonomous vehicles in production environments and in 2023 began licensing EAS commercially. Built and tested in difficult and diverse real-world environments, DriveMod, the fleet management system and our proprietary Software Development Kit ("DriveMod Kit") combine to create a full-stack advanced autonomy solution designed to be modular, extendable, and safe. The Company operates in one business segment.

On June 25, 2024, the Company's stockholders voted to authorize the Company's Board of Directors to effect a reverse stock split of the outstanding shares of common stock within a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company's Board of Directors determined to effect the reverse stock split of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024. On January 30, 2025, the Company's stockholders voted to authorize the Company's Board of Directors to effect a reverse stock split of the outstanding shares of common stock within a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company's Board of Directors determined to effect the reverse stock split of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February 18, 2025.

All share and per share amounts and exercise prices of stock options and warrants in the accompanying condensed consolidated financial statements and notes to the condensed consolidated financial statements have been retroactively adjusted to reflect the reverse stock splits for all periods presented.

***Liquidity***

The Company has incurred losses from operations since inception. The Company incurred net losses of approximately $13.0 million and $11.8 million for the six months ended June 30, 2025 and 2024, respectively. Accumulated deficit amounted to approximately $202.3 million and $189.3 million as of June 30, 2025 and December 31, 2024, respectively. Net cash used in operating activities was approximately $12.8 million and $10.2 million for the six months ended June 30, 2025 and 2024, respectively.

The Company's liquidity is based on its ability to increase its operating cash flow position, obtain capital financing from equity interest investors and borrow money to fund its general operations, research and development activities, and capital expenditures. The Company's ability to continue as a going concern is dependent on management's ability to successfully execute its business plan, which includes increasing revenue while controlling operating costs and expenses and obtaining funds from outside sources to generate positive financing cash flows. As of June 30, 2025, the Company's unrestricted cash balance was approximately $31.3 million and short-term investments of approximately $7.9 million. As of December 31, 2024, the Company's cash balance was approximately $23.6 million.

Based on cash flow projections from operating, investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations and related commitments for the 12 months following the date these condensed consolidated financial statements were issued.

**2. Summary of Significant Accounting Policies**

***Basis of Presentation***

The accompanying condensed consolidated financial statements as of and for the three months ended June 30, 2025 and 2024 have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and pursuant to applicable rules and regulations of the Securities and Exchange Commission ("SEC"). These financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, which was filed with the SEC on March 6, 2025.

The accompanying unaudited condensed consolidated financial statements have been prepared on a consistent basis with the audited consolidated financial statements for the fiscal years ended December 31, 2024, and 2023, and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. There have been no changes to the Company's significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 that have had a material impact on the consolidated financial statements and the related notes.

The results reported for the interim period presented are not necessarily indicative of results that may be expected for any subsequent quarter or for the full year ending December 31, 2025. These unaudited condensed consolidated financial statements include all adjustments and accruals that are necessary for a fair statement of all interim periods reported herein.

***Principles of Consolidation***

The condensed consolidated financial statements include the accounts of Cyngn Inc. and its wholly owned subsidiary. Intercompany accounts and transactions have been eliminated upon consolidation.

***Foreign Currency Translation***

 ****

The functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the condensed consolidated financial statements.

 ****

***Use of Estimates***

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company's significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

***Concentration of Credit Risk***

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.

Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.

***Concentration of Supplier Risk***

The Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of June 30, 2025 and December 31, 2024.

***Cash and Short-term Investments***

The Company considers its bank accounts and all highly liquid investments that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of June 30, 2025 and December 31, 2024, the Company had $31.3 million of cash and $7.9 million in short-term investments and $23.6 million of cash, respectively.

The Company considers short-term investments to include marketable U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board's ("FASB") Accounting Standards Codification Topic ("ASC") 320, "Investments – Debt and Equity Securities", and recorded these securities at amortized cost on the accompanying condensed consolidated balance sheet as of June 30, 2025 and December 31, 2024.

***Accounts Receivable***

Accounts receivables are recorded at the invoiced amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for credit losses was zero as of June 30, 2025 and December 31, 2024. In addition, the Company utilizes current and historical collection data as well as assesses current economic conditions in order to determine expected trade credit losses on a prospective basis. No credit losses were recorded as of June 30, 2025 and December 31, 2024.

***Fair Value Measurements***

The accounting guidance under ASC Topic 820, Fair Value Measurement, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

The Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:

Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Assets and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily result in a change in the amount recorded on the condensed consolidated balance sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon initial recognition.

The carrying amounts of the Company's cash and accounts receivable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company's share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent external valuations.

***Property and Equipment***

Property and equipment is stated at cost less accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the Company's autonomous driving software. Assets are held as construction work in progress until placed into service, at which date depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over each asset's estimated useful life. Repair and maintenance costs are expensed as incurred.

---

| | |
|:---|:---|
| **Property and Equipment** | **Useful life** |
| Automobiles (DMV-registered) | 5 years |
| Machinery, tools and equipment | 5 years |
| Computer and equipment | 5 years |
| Internal-use software | 3 to 5 years |
| Furniture and fixtures | 7 years |
| Leasehold improvements | Shorter of 3 years<br> or lease term |

---

 ****

***Operating Leases***

The Company accounts for leases in accordance with ASC Topic 842 ("ASC 842"), Leases. All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the condensed consolidated balance sheets under ASC 842 on the office space lease in Mountain View, California that commenced in May 2025 and the previous office space lease in Menlo Park, California that ended in May 2025. Lease expense will be recognized on a straight-line basis over the remaining term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.

***Costs to Develop Software***

 ****

The Company incurs costs related to internally developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.

 ****

***Internal-Use Software costs***

The Company determined when to capitalize its internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs, as well as subscription server and consulting costs.

Internal-use software is classified as property and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. No impairment charges were associated with the Company's internal-use software for the three and six months ended June 30, 2025 and 2024.

***Costs to Develop Software to be Sold, Leased or Otherwise Marketed***

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred to develop functionality for the Company's software and internally built software platforms, as well as certain upgrades and enhancements that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility of a product is established. Management has determined that technological feasibility is established when a working model is complete. After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the product or enhancement is available for general release to customers.

Computer software to be sold, leased or otherwise marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount computed using the ratio that current gross revenue for a product bear to total of current and anticipated future gross revenue for that product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated economic life of the product, not to exceed three years to five years and recorded as cost of revenue. Amortization will begin when the product or enhancement is available for general release to customers. No amortization has begun for externally sold software, as the software enhancement is still in development. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. No impairment charges were associated with the Company's sold, leased or otherwise marketed software for the three and six months ended June 30, 2025 and 2024.

***Long-Lived Assets and Finite Lived Intangibles***

The Company has finite-lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.

The Company reviews its long-lived assets and finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset.

The Company also identified that the long-lived asset "Patents", which have international and U.S. based patents, as the asset group. The Company evaluated its patents and identified expired international patent applications ("expired assets") for the year ended December 31, 2024. The Company determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying value was set to its salvage value which is zero given no future cash flows.

For the three and six months ended June 30, 2024, the Company determined the existence of an impairment associated with the Company's intangible asset "Patents" and accordingly recorded an impairment charge of $66,107 and $118,831, respectively (see Note 6. Intangible Assets). For the three and six months ended June 30, 2025, there were no impairment charges.

***Income Taxes***

The Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.

A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company's lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance as of June 30, 2025 and December 31, 2024 (see Note 11. Income Taxes).

There are no uncertain tax positions that would require recognition in the condensed consolidated financial statements. If the Company were to incur an income tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management's conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon on ongoing analysis of or changes in tax laws, regulations and interpretations thereof as well as other factors.

***Common Stock Warrants***

 ****

The Company issued to its lead underwriter in the Company's IPO warrants to purchase up to 9 shares of the Company's common stock. In addition, the Company issued 426 common stock warrants as a part of the private placement offering. The Company accounts for warrants in accordance with ASC 480, "Distinguishing Liabilities from Equity". The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.

 ****

The Company also applied the guidance in ASC 340-10-S99-1, Other Assets and Deferred Costs, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance of an equity contract, and accordingly, classified the warrants as additional paid-in capital.

The Company issued Series A warrants and Series B warrants in connection with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, Distinguishing Liabilities from Equity, depending on the specific terms of the warrant agreement. The estimated fair value of the Company's warrant agreements has been determined to be Level 3 measurement, as certain inputs used to determine the fair value of these agreements are unobservable. The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of the issuer's equity shares in the warrant agreements. The resulting warrant liabilities are re-measured at each balance sheet date until their exercise or expiration, and any change in fair value is recognized in the Company's consolidated statements of operations under other income (expense). After shareholder approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore, in accordance with ASC 815-40-35-8, *Derivatives and Hedging Reclassification of Contracts*, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants are included in equity in the condensed consolidated balance sheet as of June 30, 2025. The Series B warrants were re-measured utilizing the Black Scholes model immediately before exercise and were fully exercised in February 2025. Due to the Series A reclassification to equity and the exercising of the Series B warrants, the Company expensed the total of $0.9 million of liability issues costs to change in fair value of the warrant liability for the six months ended June 30, 2025.

 ****

***Stock-based Compensation***

The Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense).

***Net Loss Per Share Attributable to Common Stockholders***

The Company computes loss per share attributable to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable to Common Stockholders).

***Research and Development Expense***

Research and development expenses consists primarily of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company personnel involved in the development of the Company's products and services, and allocated lease costs based on the approximate square footage area used in research and development activities. Research and development costs are expensed as incurred.

 **

***Selling, General, and Administrative Expense***

 **

Selling, general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance with ASC 720-35, "Other Expense – Advertising Costs", other than trade show expenses which are deferred until occurrence of the future event. Advertising costs for the three months ended June 30, 2025 and 2024 were $136,697 and $39,900, respectively. Advertising costs for the six months ended June 30, 2025 and 2024 were $212,434 and $130,999, respectively.

***Commitments***

 ****

The Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company as of June 30, 2025 and December 31, 2024.

 **

***Segment Reporting***

 **

The Company operates as one operating segment. The Company's chief operating decision maker is the executive management team, its Chief Executive Officer and Chief Financial Officer. The executive management team manages operations and business as one operating segment for the purposes of allocating resources, making operating decisions and evaluating financial performance.

The one operating segment generates revenues from EAS subscriptions with relative add-on offerings such as hardware revenue and other revenue (i.e., deployment/set up costs) and fixed-price NRE contracts related to customer-specific configuration that consist of several independent phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod software, and demonstrations.

For the Company's one segment, the executive management team use revenue and net loss to allocate resources, both reported on the condensed Consolidated Statement of Operations as Revenue and Net loss. The executive management team also uses revenue and net loss, along with non-financial inputs and qualitative information, to evaluate the Company's performance, establish compensation, monitor budget versus actual results, and decide the level of investment in various operating activities and other capital allocation activities. The measure of segment assets is reported on the condensed Consolidated Balance Sheet as Total assets.

  **

***Revenue Recognition***

 **

Under ASC 606, "Revenue from Contracts with Customers", the Company determines revenue recognition through the following steps:

● Identifying the contract, or contracts, with the customer;

● Identifying the performance obligations in the contract;

● Determining the transaction price;

● Allocating the transaction price to performance obligations in the contract; and

● Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.

Nature of Products and Services and Revenue Recognition from (a) subscription of our Enterprise Autonomy Service ("EAS"), (b) nonrecurring engineering services under fixed fee arrangements ("NRE services"), (c) product sales of hardware to customers and distributors, and (d) other are recognized as follows:

*Subscription*

Subscription revenue primarily consists of the sale of SaaS offerings. Through the SaaS offerings and related support services, customers are granted access to a hosted software application over the contract period, generally ranging from one year to five years, without a contractual right to possession of the software.

SaaS and related support services: Revenues from the sale of hosted software applications and related support services are generally recognized ratably over the contractual period that the services are delivered, beginning on the date the service is made available to customers. Revenue is recognized ratably because the customer simultaneously receives and consumes the benefits of the services throughout the contract period. Contracts are generally fixed price the Company's standard payment terms vary by customer and the products or services offered.

Revenue is measured based on considerations specified in a contract with a customer. Customer contracts for software subscriptions are generally represented by a sales contract or purchase order with contract durations typically ranging from three to five years.

For the three months ended June 30, 2025 and 2024, subscription revenue was $17,986 and $3,624, respectively, and for the six months ended June 30, 2025 and 2024 was $29,846 and $6,351, respectively.

 ****

*Non-Recurring Engineering ("NRE")*

 ****

The Company enters into Non-Recurring Engineering ("NRE") contracts that are principally comprised of engineering services related to customer-specific configuration of the DriveMod. Generally, with respect to these NRE contracts, i) the determination of the contract price is based on labor and hardware costs estimated to achieve the required milestones specified in the contract; ii) payment under these arrangements are comprised of upfront payments due upon execution of the agreements as well as payments due upon the achievement of milestones specified in each arrangement; and iii) contain mutual termination clauses without penalty. The Company recognizes revenue from NRE contracts that are fully funded by customers and the sale of its products when promised goods or engineering services are transferred to customers. Each of the Company's NRE arrangements are comprised of multi-phase deliverables recognized at a point in time upon completion and acceptance from the customer of each phase of the arrangement. The Company recognizes revenue in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

For the three months ended June 30, 2025 and 2024, NRE revenue was $0, and for the six months ended June 30, 2025 and 2024 was $0.

*Hardware*

Hardware Revenue generally consists of sale or lease of industrial vehicles modified with a proprietary autonomous hardware kit, known as a DriveMod Kit. Revenue is recognized at a point in time when title and risks and rewards of ownership have transferred to the customer. For customers that lease the hardware, revenue is recognized over time as the customer simultaneously receives and consumes the benefits provided by the hardware. Customer contracts for product sales of hardware are generally represented by a sales contract or purchase order.

 

For the three months ended June 30, 2025 and 2024, hardware revenue was $10,578 and $5,042, respectively, and for the six months ended June 30, 2025 and 2024 was $20,516 and $7,828, respectively.

 

 

*Royalty*

Royalty revenue primarily consists of the licensing of the proprietary software that operates and is integrated into the DriveMod Kit. In these arrangements, the software is not distinct from the hardware, as it does not have standalone functionality without the underlying hardware and is highly interrelated with the operation of the hardware. As such, the Company accounts for the software and hardware as a single combined performance obligation and royalty revenue is recognized in the period in which the underlying products, DriveMod Kits, are sold.

For the three months ended June 30, 2025 and 2024, royalty revenue was $0, and for the six months ended June 30, 2025 and 2024 was $25,200 and $0, respectively.

*Other*

Other revenues generally consist of fees associated with the sale of distinct professional services, either in support of deploying hardware and subscription support. Professional service offerings are typically sold as part of an arrangement for products or services included within subscription revenue. Professional services associated with subscription revenue generally relate to standard implementation, configuration, installation or training services applied to SaaS deployment models. Professional service revenue is recognized over time as the services are performed, as the customer simultaneously receives and consumes the benefit of these services. Professional service contracts are offered at either a fixed or a variable price and may be invoiced in advance or arrears of the services being provided.

The Company's standard payment terms vary by customer and the products or services offered. Contract terms for other revenue arrangements are generally short-term, with stated contract terms that are less than one year.

The Company collects and remits taxes assessed by different governmental authorities that are both imposed on and concurrent with a revenue-producing transaction between the Company and the Company's customers. These taxes may include, but are not limited to, sales, use, value-added, and some excise taxes. The Company reports the collection of these taxes on a net basis (excluded from revenues). Shipping and handling fees billed to customers are included in net sales, while costs of shipping and handling are included in cost of revenue.

For the three months ended June 30, 2025 and 2024, other revenue was $5,162 and $0, respectively, and for the six months ended June 30, 2025 and 2024 was $5,317 and $0, respectively.

*Arrangements with Multiple Performance Obligations*

When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated stand-alone selling price. The transactions to which the Company had to estimate stand-alone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.

The Company's contracts may include standard warranty or service level provisions that state promised goods and services will perform and operate in all material respects as defined in the respective agreements. The Company has determined that these represent assurance-type warranties, and the Company has not incurred any material costs as a result of such commitments.

*Cost to Obtain and Fulfill a Contract*.

The Company incurs certain costs to obtain contracts, principally third-party fulfillment fees, which the Company capitalizes when the liability has been incurred if they are (i) incremental costs of obtaining a contract, (ii) expected to be recovered and (iii) have an expected amortization period that is greater than one year (as the Company has elected the practical expedient to expense any costs to obtain a contract when the liability is incurred if the amortization period of such costs would be one year or less).

*Material Rights*

The Company's contracts with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material right and therefore need to be accounted for as separate performance obligations requires judgment. The price of each option must be assessed to determine whether it is reflective of the stand-alone selling price or is reflective of a discount that the customer only received as a result of its prior purchase (a material right).

*Other Policies, Judgments and Practical Expedients*

*Contract balances*. Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company's customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.

*Remaining performance obligations*. Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.

*Significant financing component*. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company's contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.

*Contract modifications*. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the stand-alone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.

*Principal vs. Agent Considerations*

Judgment is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., "gross"), or we arrange for other parties to provide the service to the end-user and are an agent (i.e., "net"). This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts and promotions offered to end-users to the extent they are not customers.

In dealer transactions where our role is to provide the hardware to the dealer, we do not control and are not primarily responsible for the good or service provided by the dealer to end-users. In these transactions, hardware revenue is recorded on a net basis.

In dealer and OEM transactions where our role is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.

*Judgments and estimates.* Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method and residual method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.

***Concentration of Credit Risk***

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the three months ended June 30, 2025 and 2024, respectively.

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Customer A | \* | 22.8% |
| Customer B | 33.4% | \* |
| Customer C | 31.0% | \* |
| Customer D | 29.7% | 69.2% |

---

\* Below 10%

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the six months ended June 30, 2025 and 2024, respectively.

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| Customer A | \* | 13.9% |
| Customer B | 22.3% | \* |
| Customer C | 31.2% | \* |
| Customer D | 25.9% | \* |
| Customer E | 18.2% | 81.2% |

---

\* Below 10%

There was $102,189 from these customers in accounts receivable at June 30, 2025 and $269,500 from these customers in accounts receivable at December 31, 2024.

***Cost of Revenue***

Cost of revenue consists primarily of direct labor and related fringe benefits for internal engineering resources, and deployment related travel costs incurred for the completion of the contracts and hardware costs.

**3. Revenue and Contracts with Customers**

**Contract Balances**

Timing differences between revenue recognized, billings, and customer payments result in contract assets and liabilities. Contract assets represent revenue recognized in excess of customer billings. Contract liabilities represent payments received from customers in advance of satisfying performance obligations. The Company had contract assets of $2,394 and contract liabilities of $4,420 as of June 30, 2025. The Company had contract assets of $3,007 and contract liabilities of $3,333 as of December 31, 2024.

**Deferred Contract Costs**

The Company defers costs associated with fulfilling its contracts if those costs meet all of the following criteria: (i) the costs relate directly to a contract, (ii) the costs generate or enhance resources of the Company that will be used in satisfying performance obligations in the future, and (iii) the costs are expected to be recovered. Costs are recognized over the life of the contract or when the respective milestone has been completed as cost of revenue. The Company had deferred contract costs totaling $262,124 and $120,793 as of June 30, 2025 and December 31, 2024, respectively. Deferred contract costs are included in prepaid and other current assets in the condensed consolidated balance sheets.

**4. Balance Sheet Components**

 ****

***Financial Instruments***

The Company's short-term investments consisted of U.S. government treasury bills, which are accounted for as held-to-maturity ("HTM") securities. HTM securities are carried at amortized cost and, as a result, are not remeasured to fair value on a recurring basis. As of June 30, 2025 and December 31, 2024, the amortized cost of the Company's U.S. government treasury bills totaled $7.9 million and $0, respectively, which approximated its fair value based on Level 1 inputs. All of the Company's short-term investments will mature within one year of June 30, 2025. The Company does not expect a credit loss for its short-term investments.

 ****

***Prepaid expenses and other current assets***

Prepaid expenses and other current assets are comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **June 30,<br> 2025** | **December 31,<br> 2024** |
| Inventory | $985722 | $150241 |
| Prepaid Expenses | 2107413 | 303803 |
| Short-term Security Deposits | 163149 | 160149 |
| Tax Receivables | 771269 | 765598 |
| Receivables and current assets | 372245 | 585431 |
| &nbsp;&nbsp;&nbsp;Total prepaid and expenses and other current assets | $4399798 | $1965222 |

---

***Property and Equipment, Net***

Property and equipment is comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **June 30,**<br>**2025** | **December 31,**<br>**2024** |
| Automobiles (DMV-registered) | $28862 | $128862 |
| Machine, tools and equipment | 693595 | 660155 |
| Computers and equipment | 398826 | 389007 |
| Capitalized software | 1239178 | 950832 |
| Furniture and fixtures | 66182 | 66182 |
| Leasehold improvements | – | 221977 |
| Testing equipment (Work in Progress) | 703820 | 687986 |
| &nbsp;&nbsp;&nbsp;Property and equipment, gross | 3130463 | 3105001 |
| Less: accumulated depreciation and amortization | (579699) | (785599) |
| &nbsp;&nbsp;&nbsp;Total property and equipment, net | $2550764 | $2319402 |

---

Depreciation expense for the three months ended June 30, 2025 and 2024 was $51,856 and $50,052, respectively, and for the six months ended June 30, 2025 and 2024 was $107,678 and $96,886, respectively.

 

***Accounts Payable***

Accounts payable includes independent director fees payable of $42,500 and $28,333 as of June 30, 2025 and December 31, 2024, respectively.

***Accrued Expenses and Other Current Liabilities***

Accrued expenses and other current liabilities are comprised of the following:

---

| | | |
|:---|:---|:---|
|  | **June 30,<br> 2025** | **December 31,<br> 2024** |
| Credit card payable | $170063 | $2050 |
| Accrued expenses | 394770 | 788948 |
| Deferred revenue | 762263 | 769180 |
| Accrued payroll | 1294309 | 1314038 |
| &nbsp;&nbsp;&nbsp;Total accrued expenses and other current liabilities | $2621405 | $2874216 |

---

**5. Operating Leases**

The Company leases its office space in Mountain View, California, under an operating lease agreement dated March 25, 2025, originally signed for a term of six and one half years that commenced in May 2025. Monthly payments are approximately $110,500. The lease includes common area maintenance costs that are paid separately from rent based on actual costs incurred. The Company's previous lease in Menlo Park, California ended in May 2025.

The Company's future lease payments under the non-cancellable lease as of June 30, 2025, which are presented as lease liabilities on the Company's condensed consolidated balance sheet, are as follows:

---

| | |
|:---|:---|
| **Period** | **Operating<br> Lease** |
| Remainder in 2025 | $– |
| 2026 | 692000 |
| 2027 | 1434193 |
| 2028 | 1506260 |
| 2029 | 1551040 |
| 2030 | 1598594 |
| 2031 | 1367166 |
| Total lease payments | 8149253 |
| &nbsp;&nbsp;&nbsp;Less: imputed interest | (1529170) |
| Present value of lease liability | $6620083 |

---

---

| | | |
|:---|:---|:---|
|  | **June 30,**<br>**2025** | **December 31,**<br>**2024** |
| Weighted-average remaining lease term (in years) | 6.33 | 0.42 |
| Weighted - average discount rate | 5.60% | 4.87% |

---

Lease expense was $297,743 and $178,354 for the three months ended June 30, 2025 and 2024, respectively, and $455,040 and $359,965 for the six months ended June 30, 2025 and 2024, respectively. The amortization of the operating lease right-of-use assets, which is included in the lease expense, totaled $298,007 and $172,631 for the three months ended June 30, 2025 and 2024, respectively, and $476,124 and $343,779 for the six months ended June 30, 2025 and 2024, respectively. The weighted average discount rate is based on the incremental borrowing rate that is utilized to present value the remaining lease payments over the lease term.

**6. Intangible Assets, Net**

The gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** | **As of June 30, 2025** |
|  | **Gross Carrying Amount** | **Accumulated Amortization** | **Fair Market Value Adjustment** | **Impairment** | **Net Carrying Amount** |
| Developed software | $2590491 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $2590491 |
| Patents | 514098 | (56283) | – | – | 457815 |
| Trademark | 45000 | (27500) | – | – | 17500 |
| Total intangible assets | $3149589 | $(83783) | $– | $– | $3065806 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
|  | **Gross Carrying Amount** | **Accumulated Amortization** | **Fair Market Value Adjustment** | **Impairment** | **Net Carrying Amount** |
| Developed software | $1425689 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – | $1425689 |
| Patents | 611072 | (41856) | – | (118831) | 450385 |
| Trademark | 45000 | (26000) | – | – | 19000 |
| Total intangible assets | $2081761 | $(67856) | $– | $(118831) | $1895074 |

---

Amortization expense for the three months ended June 30, 2025 and 2024 was $8,597 and $5,914, respectively, and for the six months ended June 30, 2025 and 2024 was $15,927 and $11,827, respectively. There was no amortization expense for the developed software for the three and six months ended June 30, 2025 and 2024.

ASC 360, *Property, Plant, and Equipment*, defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present. The Company determined the Triggering Events in conjunction with preparation of its financial statements for the year ended December 31, 2024 provided such indication.

Next, the Company must review the long-lived assets to define asset group(s) that would reflect the lowest level of assets to which discrete cash flows are identifiable, and test these asset groups for impairment.

In performing this review, the Company identified that the long-lived asset "Patents", which have international and U.S. based patents, as the asset group. The Company evaluated its patents and identified expired international patent applications ("expired assets") for the year ended December 31, 2024. The Company determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying value was set to its salvage value which is zero given no future cash flows.

For the three months ended June 30, 2025 and 2024, the Company recorded a $0 and $66,107, respectively, and for the six months ended June 30, 2025 and 2024, recorded a $0 and $118,831, respectively, impairment charge under gain (loss) on disposal assets, which is included in other income (expense) on its condensed consolidated statement of operations, to adjust the expiring assets salvage value of zero.

It was determined for all remaining long-lived assets that there were no triggering events, and therefore, no further impairment charges to long-lived assets were necessary as of June 30, 2025 and December 31, 2024.

Estimated amortization expense for all intangible assets subject to amortization in future years is expected to be:

---

| | |
|:---|:---|
| **Years ended December 31,** | **Amortization** |
| Remainder 2025 | $16663 |
| 2026 | 33326 |
| 2027 | 33326 |
| 2028 | 33326 |
| 2029 | 33326 |
| Thereafter | 2915839 |
| Total | $3065806 |

---

**7. Capital Structure**

***Common Stock***

 ****

As of June 30, 2025, the Company is authorized to issue 400,000,000 shares of common stock with a par value of $0.00001 per share. As of December 31, 2024, the Company was authorized to issue 200,000,000 shares of common stock with a par value of $0.00001 per share. As of June 30, 2025 and December 31, 2024, the Company had 7,039,266 and 199,110 shares of common stock issued and outstanding, respectively. Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future

***Preferred Stock***

 ****

In October 2021, the Company amended its Certificate of Incorporation and revised the number of preferred stock shares authorized for issuance to 10,000,000 shares at a par value of $0.00001. As of June 30, 2025 and December 31, 2024, there were no shares of preferred stock issued and outstanding.

***Reverse Stock Split***

On June 25, 2024, the Company's stockholders voted to authorize the Company's Board of Directors to effect a reverse stock split of the outstanding shares of common stock within a range of 1-for-5 to 1-for-100. On June 25, 2024, the Company's Board of Directors determined to effect the reverse stock split of the common stock at a 1-for-100 ratio, which reverse split became effective in the market on July 5, 2024.

On January 30, 2025, the Company's stockholders voted to authorize the Company's Board of Directors to effect a reverse stock split of the outstanding shares of common stock within a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company's Board of Directors determined to effect the reverse stock split of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February 18, 2025.

The Company's primary reason for effecting the reverse stock splits was to increase the per share price of our common stock to meet Nasdaq's minimum bid price requirement for continued listing on Nasdaq.

***Common Stock Offerings***

 ****

On June 27, 2025, the Company entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 313,564 shares of its common stock, par value $0.00001 per share at a purchase price of $7.50 per share and 1,979,769 pre-funded warrants to purchase shares of Common Stock, at a purchase price of $ of $7.49999 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on June 30, 2025. The Company received net proceeds of approximately $14.7 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On June 26, 2025, the Company entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 192,496 shares of its common stock, par value $0.00001 per share at a purchase price of $5.01 per share and 2,801,516 pre-funded warrants to purchase shares of Common Stock, at a purchase price of $ of $5.00999 per pre-funded warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on June 27, 2025. The Company received net proceeds of approximately $12.7 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On December 30, 2024, the Company entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 44,333 shares of its common stock, par value $0.00001 per share at a purchase price of $90 per share and 55,667 pre-funded warrants to purchase shares of Common Stock, at a purchase price of $89.985 per Pre-Funded Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on December 31, 2024. The Company received net proceeds of approximately $8.1 million from the Offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On December 20, 2024, the Company entered into a securities purchase agreement for the sale and issuance of (i) 20,507 units at a public offering price per Unit of $241.50 with each Unit consisting of one share of common stock, par value $0.00001 per share, one Series A warrant to purchase one share of Common Stock at an exercise price of $301.875 per share and one Series B warrant to purchase one share of Common Stock at an exercise price of $301.875 and (ii) 62,309 pre-funded units at a public offering price of $241.485 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.015 per share, one Series A Warrant and one Series B Warrant. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on December 23, 2024. The net proceeds to the Company from the Offering were approximately $18.2 million, after deducting placement agent's fees and the payment of other estimated offering expenses associated with the offering that are payable by the Company.

On April 23, 2024, the Company entered into an underwritten Agreement with Aegis Capital Corp. ("Aegis"), pursuant to which Aegis acted as the Company's underwriter on a firm commitment basis in connection with the sale by the Company of an aggregate of 3,333 shares of common stock in a public offering, which included: (i) 1,320 shares of common stock, and (ii) pre-funded warrants to purchase 2,013 shares of common stock. The Pre-Funded Warrants had a nominal exercise price of $0.15. Each share of common stock was sold at an offering price of $1,500, and each Pre-Funded Warrant was sold at an offering price of $1,499.85. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on April 25, 2024. On May 3, 2024, the Company closed on the sale of an additional 136 shares of common stock, upon exercise by the underwriter of the over-allotment option. The Company received net proceeds of approximately $4.6 million, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

***At the Market Equity Financing***

 ****

On May 31, 2023, the Company entered into an ATM Sales Agreement with Virtu Americas LLC (the "ATM Sales Agreement"), under which the Company may, from time to time, sell shares of the Company's common stock at market prices by methods deemed to be an "at-the-market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The ATM Sales Agreement and related prospectus is limited to sales of up to an aggregate maximum $8.8 million of shares of the Company's common stock. The Company pays Virtu Americas LLC up to 3.0% of the gross proceeds as a commission. As of December 31, 2024, a total of 4,524 shares of common stock were sold through Virtu Americas LLC under the ATM Sales Agreement. As of December 31, 2024, the Company has received net proceeds of $8,597,957 after payment of commission fees of $175,468 and other related expenses of $60,465. No shares of common stock were sold through Virtu Americas LLC under the ATM Sales Agreement in the current reporting period.

***Private Placement Offering***

On November 12, 2024, the Company entered into a Securities Purchase Agreement ("SPA") with certain investors pursuant to which we sold, in a private placement, senior notes with an aggregate principal amount of $4,375,000 (the "Notes"), and received proceeds before expenses of $3,500,000. The Notes matured on February 12, 2025, with 20% interest rate. As consideration for entering into the SPA, we issued a total of 2,701 shares of common stock of the Company to the Purchasers on November 13, 2024. The common stock and the Notes were recorded at the relative fair values in accordance with ASC 470-20-25-2. The placement agent fee and other offering expenses were allocated based on the aforementioned fair values as a reduction to the carrying amount of the debt and a reduction of the equity in accordance with ASC 505-10. The amortization of the debt discount and issuance costs was recorded in interest income (expense) on the condensed consolidated statement of operations. As of December 31, 2024, the Notes were paid in full.

***Common Stock Warrants***

 ****

The following warrants were outstanding as of June 30, 2025, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock dividends or other extraordinary dividends, or other similar changes in the Company's common stock or capital structure, and none of which have any participating rights for any losses. All Series B warrants, which were issued as a part of the December 20, 2024 public offering, were fully exercised as of February 11, 2025 utilizing the cashless exercise provision in the warrant agreement.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Securities into which warrants are convertible** | **Warrants<br> outstanding** | **Exercise<br> Price** | **Expiration<br> Date** | **Fair<br> value** |
| Common stock (Initial Public Offering) | 9 | $40650 | October 2026 | $170397 |
| Common stock (Private Placement) | 426 | $140625 | April 2027 | 6071114 |
| Common stock (Series A) | 517598 | $48.30 | January 2030 | 7634428 |
| Total | 518033 |  |  | $13875939 |

---

The following warrants were outstanding as of December 31, 2024, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock dividends or other extraordinary dividends, or other similar changes in the Company's common stock or capital structure, and none of which have any participating rights for any losses:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Securities into which warrants are convertible** | **Warrants<br> outstanding** | **Exercise<br> Price** | **Expiration<br> Date** | **Fair<br> value** |
| Common stock (Initial Public Offering) | 9 | $40650 | October 2026 | $170397 |
| Common stock (Private Placement) | 426 | $140625 | April 2027 | 6071114 |
| Common stock (Series A) | 277778 | $90 | January 2030 | 6581789 |
| Common stock (Series B) | 82816 | $301.88 | July 2027 | 21122138 |
| Total | 361029 |  |  | $33945438 |

---

The Company accounts for warrants in accordance with ASC 480, *Distinguishing Liabilities from Equity*, depending on the specific terms of the warrant agreement. The Company determined the fair value of the Initial Public Offering and Private Placement warrants using the Black-Scholes pricing model and treated the valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements. The warrants are not marked-to-market each reporting period, and thus there is no impact to earnings. Any future exercises of the warrants will be recorded as cash received and recorded in cash, with a corresponding increase to common stock and additional paid-in capital in stockholders' equity.

The Company used the following assumptions for June 30, 2025 and December 31, 2024:

---

| | | |
|:---|:---|:---|
|  | **Initial<br> Public<br> Offering<br> Warrants** | **Private<br> Placement Warrants** |
| Fair value of underlying securities | $2.88 | $1.37 |
| Expected volatility | 51.0% | 45.0% |
| Expected term (in years) | 5.0 | 5.0 |
| Risk-free interest rate | 1.13% | 2.92% |

---

Under ASC 815-40-35-8, *Derivatives and Hedging Reclassification of Contracts*, shareholder approval on January 30, 2025, initiated the price reset period, resulting in a fixed exercise price for the warrants. As such, the warrants were reclassified to equity and remeasured utilizing the Black Scholes model with the following assumptions:

---

| | |
|:---|:---|
|  | **Series A<br> Warrants** |
| Fair value of underlying securities | $14.75 |
| Expected volatility | 183.38% |
| Expected term (in years) | 4.96 |
| Risk-free interest rate | 4.30% |

---

The fair value of the Series B warrants were re-measured prior to exercise using the Black-Scholes model, now that the exercise price has been fixed, based on the following assumptions:

---

| | |
|:---|:---|
|  | **Series B<br> Warrants** |
| Fair value of underlying securities | $6.01 – 32.19 |
| Expected volatility | 162.99 – 190.53% |
| Expected term (in years) | 2.46 – 2.49 |
| Risk-free interest rate | 4.18 – 4.30% |

---

The Company accounts for warrants in accordance with ASC 480, *Distinguishing Liabilities from Equity*, depending on the specific terms of the warrant agreement. In accordance with ASC 470-20, *Debt,* the Company allocated the proceeds of the deal based on the relative fair values for the Series A and Series B warrants. The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of the issuer's equity shares in the warrant agreements for the year-ended December 31, 2024.

The Company used the following assumptions:

---

| | | |
|:---|:---|:---|
|  | **Series A<br> Warrants** | **Series B<br> Warrants** |
| Fair value of underlying securities | $0.85 | $0.85 |
| Expected volatility | 161.78% | 161.78% |
| Expected term (in years) | 5.0 | 5.0 |
| Risk-free interest rate | 4.29% | 4.29% |

---

**8. Net Loss Per Share Attributable to Common Stockholders**

In accordance with ASC 260, basic and diluted earnings per shares amounts, and weighted-average shares outstanding have been restated for all periods presented to reflect the effect of the stock dividends and reverse stock split. The following table summarizes the computation of basic and diluted loss per share:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br> June 30,** | **Three Months Ended<br> June 30,** |
|  | **2025** | **2024** |
| Net loss attributable to common stockholders | $(5472517) | $(5818952) |
| Basic and diluted weighted average common shares outstanding | 2017228 | 9526 |
| Loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic and diluted | $(2.70) | $(610.85) |

---

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended<br> June 30,** | **Six Months Ended<br> June 30,** |
|  | **2025** | **2024** |
| Net loss attributable to common stockholders | $(13065359) | $(11789031) |
| Basic and diluted weighted average common shares outstanding | 1586453 | 7748 |
| Loss per share: |  |  |
| &nbsp;&nbsp;&nbsp;Basic and diluted | $(8.22) | $(1521.56) |

---

Basic loss per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect of unvested restricted stock awards and the convertible preferred stock; however, such items were not considered in the calculation of the diluted weighted average common shares outstanding since they would be anti-dilutive.

**9. Stock-based Compensation Expense**

 ****

***Stock-Based Compensation***

The Company uses stock-based compensation, including restricted stock units, to provide long-term performance incentives for its employees and board directors. The Company measures employee and director stock-based compensation awards based on the award's estimated fair value on the date of grant. Forfeitures are recognized as they occur. Expense associated with these awards is recognized using the straight-line attribution method over the requisite service period for stock options, restricted stock units ("RSUs") and restricted stock and is reported in our condensed consolidated statements of stockholders' equity.

The fair value of the Company's stock options is estimated using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.

Determining the grant date fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts recorded.

The assumptions and estimates for valuing stock options are as follows:

● *Fair value per share of Company's common stock.* Because there was no public market for Cyngn's common stock prior to the IPO, its Board of Directors, with the assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock options by considering a number of objective and subjective factors, including its actual operating and financial performance, market conditions and performance of comparable publicly traded companies, developments and milestones in the company, and the likelihood of achieving a liquidity event among other factors. Since the Company's common stock began publicly trading on the Nasdaq, the value of its common stock underlying stock options or RSUs have been valued based on prevailing market prices.

● *Expected volatility*. Because the Company's common stock had no publicly traded history prior to the IPO, it estimated the expected volatility using a combination of its stock price volatility and the stock price volatility of peer companies, for a period equal to the expected term of the options.

● *Expected term.* The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company estimates the expected term of options granted based upon the "simplified method" provided under *Staff Accounting Bulletin, Topic 14*, or SAB Topic 14.

● *Risk-free interest rate.* The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.

● *Estimated dividend yield.* The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable future.

***Equity Incentive Plans***

In February 2013, the Company's Board of Directors adopted the 2013 Equity Incentive Plan ("2013 Plan"). The 2013 Plan authorizes the award of stock options, stock appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.

In October 2021, the Company's Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the "2021 Plan"). The 2021 Plan replaces the 2013 Plan. However, awards outstanding under the 2013 Plan will continue to be governed by their existing terms.

In November 2023, the shareholders of the Company approved an amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 334 shares of common stock. In June 2024, the shareholders of the Company approved an amendment to allow an annual increase to the 2021 Plan equal to the least of (i) 15% of the outstanding common stock on a fully diluted basis as of the end of the Company's immediately preceding fiscal year, or (ii) such lesser amount as determined by the Board.

As of June 30, 2025 and December 31, 2024, approximately 55,646 and 614 shares of common stock were reserved and available for issuance under the 2021 Plan, respectively. Options issued under the Plans generally vest based on continuous service provided by the option holder over a four-year period. Compensation expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant date.

The following table summarizes information about the Company's stock options outstanding as well as stock options vested and exercisable as of June 30, 2025, and activity during the three month period then ended:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Shares** | **Weighted-<br> average exercise<br> price** | **Weighted-<br> average remaining<br> contractual<br> term<br> (years)** | **Aggregate<br> intrinsic<br> value** |
| Outstanding as of March 31, 2025 | 1103 | $14629.79 | 5.98 | $– |
| &nbsp;&nbsp;&nbsp;Granted | – | – |  |  |
| &nbsp;&nbsp;&nbsp;Exercised | – | – |  | – |
| Cancelled/forfeited | (55) | $12872.29 | – |  |
| Outstanding as of June 30, 2025 | 1048 | $14722.02 | 5.19 | $– |
| Vested and expected to vest at June 30, 2025 | 1048 | $14722.02 | 5.19 | $– |
| Vested and exercisable at June 30, 2025 | 797 | $15030.02 | 4.38 | $– |

---

The following table summarizes information about the Company's stock options outstanding as well as stock options vested and exercisable as of June 30, 2025, and activity during the six month period then ended:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Shares** | **Weighted-<br> average exercise<br> price** | **Weighted-<br> average remaining<br> contractual<br> term<br> (years)** | **Aggregate<br> intrinsic<br> value** |
| Outstanding as of December 31, 2024 | 1151 | $14665.36 | 7.37 | $– |
| &nbsp;&nbsp;&nbsp;Granted | – | – |  |  |
| &nbsp;&nbsp;&nbsp;Exercised | – | – |  | – |
| Cancelled/forfeited | (103) | $13989.48 | – |  |
| Outstanding as of June 30, 2025 | 1048 | $14722.02 | 5.19 | $– |
| Vested and expected to vest at June 30, 2025 | 1048 | $14722.02 | 5.19 | $– |
| Vested and exercisable at June 30, 2025 | 797 | $15030.02 | 4.38 | $– |

---

The following table summarizes information about the Company's RSUs as of June 30, 2025, and activity during the three months then ended:

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Weighted-<br> average<br> grant date<br> fair value** |
| Unvested Shares at March 31, 2025 | 15 | $1677.00 |
| RSUs granted | – | – |
| RSUs vested | (15) | 1677.00 |
| RSUs forfeited | – | – |
| Unvested Shares at June 30, 2025 | – | $– |

---

The following table summarizes information about the Company's RSUs as of June 30, 2025, and activity during the six months then ended:

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Weighted-<br> average<br> grant date<br> fair value** |
| Unvested Shares at December 31, 2024 | 20 | $21957.75 |
| RSUs granted | – | – |
| RSUs vested | (20) | 21957.75 |
| RSUs forfeited | – | – |
| Unvested Shares at June 30, 2025 | – | $– |

---

The fair value of a stock option is estimated using the Black-Scholes option-pricing model that takes into account as of the grant date the exercise price and expected life of the option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free interest rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all option grants based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized in the financial statements upon satisfaction of the requisite service or vesting requirements.

The weighted average per share grant-date fair value of options granted during the six months ended June 30, 2025 and 2024 was $0.00 and $1,470, respectively.

The following weighted average assumptions were used in estimating the grant date fair values on June 30, 2025 and 2024:

---

| | | |
|:---|:---|:---|
|  | **June 30** | **June 30** |
|  | **2025** | **2024** |
| Fair value of common stock | $0.00 | $17.85 |
| Expected term (in years) | 0.00 | 6.02 |
| Risk-free rate | 0.00% | 4.17% |
| Expected volatility | 0.00% | 53.19% |
| Dividend yield | 0% | 0% |

---

The Company recorded stock-based compensation expense from stock options and RSUs of approximately $456,887 and $615,651, for the three months ended June 30, 2025 and 2024, respectively, and $993,131 and $1,269,675, for the six months ended June 30, 2025 and 2024, respectively.

As of June 30, 2025, total stock-based compensation cost related to outstanding unvested stock options that are expected to vest was $2.2 million. This unrecognized stock-based compensation cost is expected to be recognized over a weighted-average period of approximately 1.8 years. Income tax benefits recognized from stock-based compensation expense recognized for the year ended June 30, 2025 were immaterial due to cumulative losses and valuation allowances.

**10. Retirement Savings Plan**

Effective November 17, 2017, the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the intention to provide a measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. The Company did not offer and has not provided a company match for its 401(k) Plan.

**11. Income Taxes**

For the three and six months ended June 30, 2025 and 2024, the Company recorded income tax expense of $0. The effective tax rate is 0% for the three and six months ended June 30, 2025 and 2024.

For financial reporting purposes, the Company's effective tax rate used for the interim periods is based on the estimated full-year income tax rate. For the three and six months ended June 30, 2025, the Company's effective tax rate differs from the statutory rate, primarily due to a valuation allowance recorded against the net deferred tax asset balance. Currently, the Company is not under examination by any taxing authority.

**12. Commitments and Contingencies**

***Legal Proceedings***

The Company is subject to legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain.

Under the terms of a settlement agreement with a former placement agent, the Company may be obligated to pay to a $2.3 million cash fee and issue 370,114 warrants to purchase shares of the Company's common stock in connection with the June 27 Offering and the June 26 Offering. However, the Company has informed the former placement agent that it does not believe there is a basis for these obligations. The Company has not received a response from the former placement agent and a resolution has not been reached as of the date of this filing. The Company is currently contesting the matter and has not accrued any liability related to it. While an unfavorable outcome is reasonably possible, the Company is unable to estimate the possible loss or range of loss at this time.

There is no other material pending or threatened litigation against the Company that remains outstanding as of June 30, 2025. To avoid litigation and minimize costs, the Company agreed in principle to a one-time payment of $500,000 to settle a contract dispute, of which payment was included in accrued expenses as of December 31, 2024 and paid on March 18, 2025.

**13. Risks and Uncertainties**

The Company's business operations, operating results, and financial condition are vulnerable to certain risks and uncertainties including:

● Inflation and its related impact on costs and expenditures on domestic and foreign-sourced materials and services;

● Rising interest rates and its impact on the equity markets, investment valuations, and interest rate-sensitive calculations such as discount rate assumptions used in cash flow projections and going concern assessments;

● Effects of the Russia-Ukraine conflict such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and

● Other factors beyond its control such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.

The Company is unable to predict and quantify at this time the extent of the related potential adverse effects but continuously monitors these risks and uncertainties on its future operations and financial performance.

**14. Subsequent Events**

The Company performed a review of events subsequent to the balance sheet date through the date the condensed consolidated financial statements were issued and determined that there were no such events requiring recognition or disclosure in the condensed consolidated financial statements.

**ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

*Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to "we," "us," "our," and Cyngn refer to Cyngn Inc. and its condensed consolidated subsidiaries.*

**Overview**

We are an autonomous vehicle ("AV") technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent vehicle manufacturers, and high upfront investment commitment.

Industrial sites are typically rigid environments with consistent standards as opposed to city streets that have more variable environmental and situational conditions and diverse regulations. These differences in operational design domains will be major factors that make proliferation of industrial AVs in private settings achievable with less time and resources than AVs on public roadways. Namely, safety and infrastructure challenges are cited as roadblocks that have delayed AVs from operating on public roadways at scale. Our focus on industrial AVs simplifies these challenges because industrial facilities (especially those belonging to a single end customer that operates similarly at different sites) share much more in common than different cities do. Furthermore, our end customers own their infrastructure and can make changes more easily than governments can on public roadways.

With these challenges in mind, we are developing an Enterprise Autonomy Suite ("EAS") that leverages advanced in-vehicle autonomous driving technology and incorporates leading supporting technologies like data analytics, asset tracking, fleet management, cloud, and connectivity. EAS provides a differentiated solution that we believe will drive pervasive proliferation of industrial autonomy and create value for customers at every stage of their journey towards full automation and the adoption of Industry 4.0.

EAS is a suite of technologies and tools that we divide into three complementary categories:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. *DriveMod*,
our modular industrial vehicle autonomous driving software;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. *Cyngn Insight*, our customer-facing tool suite for monitoring and managing AV fleets (including remotely operated vehicles) and generating/aggregating/analyzing
data (including the IoT gateway device); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. *Cyngn Evolve*, our internal tool suite and infrastructure that facilitates artificial intelligence ("AI") and machine learning
("ML") training to continuously enhance our algorithms and models and provides a simulation framework (both record/rerun
and synthetic scenario creation) to ensure that data collected in the field can be applied to validating new releases.

Legacy automation providers manufacture specialized industrial vehicles with integrated robotics software for rigid tasks, limiting automation to narrow uses. Unlike these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles that have been purposely built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible with indoor and outdoor environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.

We understand that scaling of autonomy solutions will require an ecosystem made up of different technologies and services that are enablers for AVs. Our approach is to forge strategic collaborations with complementary technology providers that accelerate AV development and deployment, provide access to new markets, and create new capabilities. Our focus on designing DriveMod to be modular will combine with our experience deploying AV technology on diverse industrial vehicle form factors, which will be difficult for competitors to replicate.

We expect our technology to generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires us and our integration partners to work with a new client to map the facility, gather data, and install our AV technology within their fleet and site. We anticipate that new deployments will yield project-based revenues based on the scope of the deployment. After deployment, we expect to generate revenues by offering EAS through a Software as a Service ("SaaS") model, which can be considered the AV software component of Robotics as a Service ("RaaS").

RaaS is a subscription model that allows customers to use robots/vehicles without purchasing the hardware assets upfront. We will seek to achieve sustained revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding suite of AV and AI capabilities as organizations transition into full industrial autonomy.

Although both the components and the combined solutions of EAS are still under development, we have EAS licenses with paying customers and have piloted EAS for paid customer trial and pilot deployments. We expect EAS to continually be developed and enhanced according to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized. We expect annual R&D expenditures in the foreseeable future to exceed that of 2024. We also had limited paid deployments in 2024 that offset some of the ongoing R&D costs of continually developing EAS. We target scaled deployments to begin in 2025.

Our go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical and daily operations by (a) leveraging the relationships and existing customers of our network of strategic partners, (b) bringing AV capabilities to industrial vehicles as a software service provider, and (c) executing a robust in-house sales and marketing effort to nurture a pipeline of industrial organizations. Our focus is on acquiring new customers who are either looking (a) to embed our technology into their vehicle product roadmaps or (b) to apply autonomy to existing fleets with our vehicle retrofits. In turn, our customers are any organizations that could utilize our EAS solution, including original equipment manufacturers ("OEMs") that supply industrial vehicles, end customers that operate their own industrial vehicles, or service providers that operate industrial vehicles for end customers.

As OEMs and leading industrial vehicle users seek to increase productivity, reinforce safer working environments, and scale their operations, we believe we are uniquely positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial uses. Our long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on more than 10 different vehicle form factors that range from stockchasers and forklifts to 14-seat shuttles and 5-meter-long cargo vehicles demonstrating the extensibility of our AV building blocks.

Our strategy upon establishing a customer relationship with an OEM is to seek to embed our technology into their vehicle roadmap and expand our services to their many clients. Once we solidify an initial AV deployment with a customer, we intend to seek to expand within the site to additional vehicle platforms and/or expand the use of similar vehicles to other sites operated by the customer. This "land and expand" strategy can repeat iteratively across new vehicles and sites and is at the heart of why we believe industrial AVs that operate in geo-fenced, constrained environments are poised to create value.

**Recent Developments**

 

*June Offerings* 

 

On June 27, 2025, the Company entered into a securities purchase agreement with the institutional investors named on the signature page thereto, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the "June 27 Offering"), 313,564 shares of its common stock, par value $0.00001 per share, at a purchase price of $7.50 per share and 1,979,769 pre-funded warrants to purchase shares of common stock, at a purchase price of $7.49999 per pre-funded warrant.

The June 27 Offering was made pursuant to that certain Registration Statement on Form S-3, as amended (File No. 333-271567), which was originally filed on May 2, 2023, and declared effective by the Securities and Exchange Commission on June 13, 2023, including the prospectus contained therein and a prospectus supplement dated June 27, 2025 filed with the Securities and Exchange Commission on June 30, 2025.

The closing of the June 27 Offering occurred on June 30, 2025. The Company received net proceeds of approximately $14.7 million from the June 27 Offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees. The Company intends to use the net proceeds from the June 27 Offering for general corporate purposes, including working capital.

In connection with the June 27 Offering, the Company entered into a placement agent agreement with Aegis Capital Corp., as the exclusive placement agent in connection with the June 27 Offering. As compensation, the Company paid Aegis Capital Corp. a cash fee of 7% of the aggregate gross proceeds raised in the June 27 Offering and reimbursed certain of its expenses.

On June 26, 2025, the Company entered into a securities purchase agreement with the institutional investors named on the signature page thereto, pursuant to which the Company agreed to sell and issue, in a registered direct offering (the "June 26 Offering"), 192,496 shares of its common stock, par value $0.00001 per share, at a purchase price of $5.01 per share and 2,801,516 pre-funded warrants to purchase shares of common stock, at a purchase price of $5.00999 per pre-funded warrant.

The June 26 Offering was made pursuant to that certain Registration Statement on Form S-3, as amended (File No. 333-271567), which was originally filed on May 2, 2023, and declared effective by the Securities and Exchange Commission on June 13, 2023, including the prospectus contained therein and a prospectus supplement dated June 26, 2025 filed with the Securities and Exchange Commission on June 27, 2025.

The closing of the June 26 Offering occurred on June 27, 2025. The Company received net proceeds of approximately $12.7 million from the June 26 Offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees. The Company intends to use the net proceeds from the June 26 Offering for general corporate purposes, including working capital.

In connection with the June 26 Offering, the Company entered into a placement agent agreement with Aegis Capital Corp., as the exclusive placement agent in connection with the June 26 Offering. As compensation, the Company paid Aegis Capital Corp. a cash fee of 7% of the aggregate gross proceeds raised in the June 26 Offering and reimbursed certain of its expenses.

Under the terms of a settlement agreement with a former placement agent, the Company may be obligated to pay to a $2.3 million cash fee and issue 370,114 warrants to purchase shares of the Company's common stock in connection with the June 27 Offering and the June 26 Offering. However, the Company has informed the former placement agent that it does not believe there is a basis for these obligations. The Company has not received a response from the former placement agent and a resolution has not been reached as of the date of this filing. While an unfavorable outcome is reasonably possible, the Company is unable to estimate the possible loss or range of loss and has not accrued any loss related to this matter at this time.

*Departure of Officer and Appointment of Officers*

 

On May 6, 2025, the Company's Board of Directors appointed Natalie Russell to serve as Interim Chief Financial Officer. Mrs. Russell was appointed to replace Donald Alvarez who on May 5, 2025, tendered his resignation as Chief Financial Officer of the Company. Mr. Alvarez' resignation and Mrs. Russell's appointment took effect on June 6, 2025.

Also on May 6, 2025, the Company's Board, named Martin Petraitis, Vice President of Sales, as a named executive officer.

 

*Amendment to Employment Agreement*

On March 6, 2025, the Company entered into a letter agreement with Lior Tal, its CEO (the "Letter Agreement"), amending his employment agreement dated January 1, 2022 (the "Employment Agreement"). Pursuant to the Letter Agreement, Mr. Tal's Employment Agreement was amended to provide for (i) a modification of his annual base salary to $640,000 effective January 1, 2025, (ii) a modification of his annual bonus to be eligible to earn an annual performance bonus in the target amount of up to $640,000 (the "Annual Bonus"), (iii) Mr. Tal shall be eligible to earn a special bonus for performance for 2025 of up to $1,000,000 ("2025 Special Bonus"), payable in January 2026, and (iv) Mr. Tal shall be eligible to earn a time-based 2025-2026 special bonus of up to $1,600,000 (the "2025-2026 Special Bonus"), payable in eight (8) quarterly installments of $200,000, with the first installment to be paid following Q1 2025, subject to such terms included in the Letter Agreement. Unless otherwise agreed in writing by the parties in a mutually executed amendment to the Employment Agreement, no special bonuses shall be paid after 2026, and the non-payment of any special bonus after 2026 shall not constitute "Good Reason" within the meaning of the Employment Agreement. Neither the 2025 Special Bonus nor the 2025-2026 Special Bonus shall be included in the Severance or the CIC Severance as such terms are defined in the Employment Agreement.

*Series B Warrants Exercises*

 

As of February 28, 2025, all the Series B warrants, in connection with the securities purchase agreement in December 2024, were exercised for a total of 232,919,252 shares.

*Nasdaq Compliance*

On February 6, 2025, the Company received a notification letter from The Nasdaq Stock Market LLC advising that, for 30 consecutive business days preceding the notification letter, the Company did not meet the minimum $1.00 per share bid price requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Marketplace Listing Rule 5550(a)(2). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Minimum Bid Price Requirement. However, pursuant to Listing Rule 5810(c)(3)(A)(iv) the Company is not eligible for any compliance period specified in Rule 5810(c)(3)(A) because the Company has effected a reverse stock split over the prior one-year period or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one. Accordingly, the Company's securities are subject to delisting from Nasdaq unless the Company requests an appeal of this determination by February 13, 2025. The Company timely requested an appeal of the determination, and a hearing is scheduled for March 18, 2025. On February 18, 2025, the Company effected a reverse stock split of its common stock and the Company's common stock has traded above $1.00 since the effectuation of the reverse stock split. On March 12, 2025, the Company received a letter from The Nasdaq Stock Market LLC stating that the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Stock Market, as set forth in Nasdaq Listing Rule 5550(a)(2). The Company will be subject to a mandatory panel monitor for a period of one year from March 12, 2025. If, within that one-year monitoring period, the Nasdaq Listing Qualifications staff (the "Staff") finds the Company is again out of compliance with the minimum bid price requirement, notwithstanding Nasdaq Listing Rule 5810(c)(2), then the Staff will issue a delist determination letter and the Company will have an opportunity to request a new hearing with the initial Nasdaq hearing panel (the "Panel") or a newly convened hearing panel if the initial Panel is unavailable.

*Reverse Stock Split*

On January 30, 2025, the Company's stockholders voted to authorize the Company's Board of Directors to effect a reverse stock split of the outstanding shares of common stock within a range of 1-for-5 to 1-for-150. On January 30, 2025, the Company's Board of Directors determined to effect the reverse stock split of the common stock at a 1-for-150 ratio, which reverse split became effective in the market on February 18, 2025. Accordingly, all share and per share data included in the condensed consolidated financial statements and applicable disclosures have been adjusted retroactively to reflect the impact of the reverse stock split.

The Company's primary reason for effecting the reverse stock split was to increase the per share price of our common stock to meet Nasdaq's minimum bid price requirement for continued listing on Nasdaq.

**Critical Accounting Policies and Estimates and Judgements**

Our condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments. We base our estimates and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known. Besides the estimates identified below that are considered critical, we make many other accounting estimates in preparing our condensed consolidated financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses, as well as disclosures of contingent liabilities. These estimates and judgments are also based on historical experience and other factors that are believed to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.

The Company considers costs to develop software, warrants and share-based compensation to be critical accounting estimates and believes the associated assumptions and estimates to have the greatest potential impact on our condensed consolidated financial statements.

***Costs to Develop Software***

 ****

The Company incurs costs related to internally developed software. Based on the nature of the software the Company capitalizes software costs under the following guidance.

 **

***Internal-Use Software***

 **

The Company capitalizes certain costs related to internal-use software, primarily consisting of direct labor and third-party vendor costs associated with creating the software. Software development projects generally include three stages: the preliminary project stage (all costs are expensed as incurred), the application development stage (certain costs are capitalized and certain costs are expensed as incurred) and the post-implementation/operation stage (all costs are expensed as incurred). Costs capitalized in the application development stage include costs related to the design and implementation of the selected software components, software build and configuration infrastructure, and software interfaces. Capitalization of costs requires judgment in determining when a project has reached the application development stage, the proportion of time spent in the application development stage, and the period over which the Company expects to benefit from the use of that software. Once the software is placed in service, these costs are amortized on the straight-line method over the estimated useful life of the software, which is generally three to five years. There is judgment involved in the determination of the useful life. Internal-use software is classified as property and equipment in accordance with ASC 350, *Intangibles – Goodwill and Other*.

***Costs to develop software to be sold, leased or otherwise marketed***

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. We have determined that technological feasibility for our software products is reached shortly after a working prototype is complete and meets or exceeds design specifications including functions, features, and technical performance requirements. After technological feasibility is established, judgment is required to determine the amount of payroll and stock-based compensation costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the product or enhancement is available for general release to customers. Computer software to be sold, leased or otherwise marketed is classified as an intangible asset in accordance with ASC 985, *Software*.

***Common Stock Warrants***

 ****

The Company issued to its lead underwriter in the Company's initial public offering consummated in October 2021, (the "IPO"), warrants to purchase up to 9 shares of its common stock, exercisable at a price per share of $140,625 and expiring on October 19, 2026. Additionally, in connection with the Private Placement offering completed on April 29, 2022, the Company issued warrants to purchase 426 shares of its common stock, exercisable at a price per share of $40,650 and expiring on April 29, 2027. The Company accounts for warrants in accordance with ASC 480, *Distinguishing Liabilities from Equity*, depending on the specific terms of the warrant agreement. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.

The Company also applied the guidance in ASC 340-10-S99-1, *Other Assets and Deferred Costs*, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance of an equity contract and, accordingly, classified the warrants as additional paid-in capital.

The Company issued Series A warrants and Series B warrants in connection with securities purchase agreement on December 20, 2024. The Company accounts for warrants in accordance with ASC 480, *Distinguishing Liabilities from Equity*, depending on the specific terms of the warrant agreement. The Company determined the fair value of the warrants using the Monte Carlo pricing model and treated the valuation as a liability in consideration of the variable number of the issuer's equity shares in the warrant agreements. After shareholder approval on January 30, 2025, the strike price and the number of equity shares are now fixed. Therefore, in accordance with ASC 815-40-35-8, *Derivatives and Hedging Reclassification of Contracts*, the Series A warrants were re-measured utilizing the Black Scholes model and reclassified into equity. The Series A warrants are included in equity in the condensed consolidated balance sheet as of June 30, 2025. The Series B warrants were re-measured utilizing the Black Scholes model immediately before exercise and were fully exercised in February 2025. Due to the Series A reclassification to equity and the exercising of the Series B warrants, the Company expensed the total of $0.9 million of liability issues costs to change in fair value of the warrant liability for the six months ended June 30, 2025.

***Stock-based Compensation***

 ****

The Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of the Company's common stock, expected price volatility of the common stock, expected term, risk-free interest rates, and expected dividend yield.

**Results of Operations**

***Revenue***

We currently derive revenue from four sources. We enter into fixed-price NRE contracts related to trial projects that consist of several independent phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod software, and demonstrations. The determination of the contract price is based on labor and hardware costs estimated to achieve the required milestones specified in the contract. The purpose of these fully funded projects is to exhibit the feasibility of the Company's technology offering to the customer on additional vehicle types and provide a level of confidence to encourage the customer to enter into a multi-year, commercial arrangement with the Company in the future. Revenue on these multi-phase contracts is generally recognized at the point in time when the performance obligations of each independent phase have been completed and customer acceptance has been acknowledged. Contracts often allow mutual termination without penalty. To the extent our actual costs vary from the fixed fee, we will generate more or less profit or could incur a loss.

In addition, we derive revenue from EAS subscriptions with relative add-on offerings such as hardware revenue and other revenue (i.e., deployment/set up costs). Revenue from these subscriptions and add-ons are recognized monthly over the service contract life, beginning at the time that a customer acknowledges acceptance of the service.

During the three and six months ended June 30, 2025, the Company recognized $33,726 and $80,878, respectively, of revenue, substantially all related to EAS subscriptions, software royalties and hardware revenue.

***Cost of Revenue***

Cost of revenues consists primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts and hardware costs.

During the three and six months ended June 30, 2025, the Company reported cost of revenue of $16,944 and $28,758, respectively, consisting primarily of deployment costs, related to personnel costs, travel expenses and associated hardware costs to specific customers.

***Research and Development***

Research and development expense consist primarily of internal engineering and development expenses, materials, labor and stock-based compensation and outsourced engineering services related to development of the Company's products and services. Research and development costs incurred during deployments are capitalized and expensed when the associated contract revenue is recognized. All other research and development costs are expensed as incurred.

Research and development expense for the three months ended June 30, 2025 decreased by approximately $1.2 million or 38.3% to $2.0 million from approximately $3.2 million for the three months ended June 30, 2024. The decrease is primarily attributable to a decrease in personnel related costs and the capitalization of costs related to capitalized software and customer contracts.

Research and development expense for the six months ended June 30, 2025 decreased by approximately $2.3 million or 35.8% to $4.1 million from approximately $6.4 million for the six months ended June 30, 2024. The decrease is primarily attributable to a decrease in personnel related costs and the capitalization of costs related to capitalized software and customer contracts.

***General and Administrative***

General and administrative expenses consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and advertising costs.

General and administrative expenses for the three months ended June 30, 2025 increased by approximately $1.0 million or 36.4% to $3.6 million from approximately $2.6 million for the three months ended June 30, 2024. The increase is primarily attributable to an increase in personnel related costs.

General and administrative expenses for the six months ended June 30, 2025 increased by approximately $1.4 million or 26.2% to $6.7 million from approximately $5.3 million for the six months ended June 30, 2024. The increase is primarily attributable to an increase in personnel related costs.

***Interest Income (Expense), net***

Interest income (expense), net increased by $196,323 to $(197,992) for the three months ended June 30, 2025 from $(1,669) for the three months ended June 30, 2024. Interest income consists primarily of interest earned of $11,601 from the Company's interest-bearing bank accounts, offset by interest expense of $209,594 related to the office lease.

Interest income (expense), net increased by $122,831 to $(123,173) for the six months ended June 30, 2025 from $(342) for the six months ended June 30, 2024. Interest income consists primarily of interest earned of $88,964 from the Company's interest-bearing bank accounts, offset by interest expense of $212,137 related to the office lease.

 ****

***Other Income (Expense), net***

Other income (expense), net increased by $256,624 to $251,545 for the three months ended June 30, 2025 from $(5,079) for the three months ended June 30, 2024. Other income consists primarily of realized gains earned on the Company's short-term investments of $249,163 and interest earned of $8,409 related to the office lease, offset by $(6,027) loss on asset disposal.

Other income (expense), net increased by $2.2 million to $(2.2) million for the six months ended June 30, 2025 from $(10,126) for the six months ended June 30, 2024. Other income consists primarily of fair value remeasurement of $(2.5) million offset by realized gains earned on the Company's short-term investments of $0.3 million.

**Liquidity and Capital Resources**

The Company's principal source of liquidity is its cash and current maturities of short-term investments. Short-term investments consist of placements in U.S. government securities with original maturities between three to nine months. As of June 30, 2025, the Company had unrestricted cash of approximately $31.3 million and short-term investments of approximately $7.9 million. As of December 31, 2024, the Company had unrestricted cash of approximately $23.6 million.

On May 31, 2023, the Company entered into an ATM Sales Agreement with Virtu Americas LLC (the "ATM Sales Agreement"), under which the Company may, from time to time, sell shares of the Company's common stock at market prices by methods deemed to be an "at-the-market offering" as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The ATM Sales Agreement and related prospectus are limited to sales of up to $8.8 million of shares of the Company's common stock. The ATM Sales Agreement expires at the earliest of 5 years after the date of the agreement or exhaustion of the aggregate limit available under the ATM Sales Agreement. The Company pays Virtu Americas LLC up to 3.0% of the gross proceeds as a commission. As of December 31, 2024, a total of 4,524, shares of common stock were sold through Virtu Americas LLC under the ATM Sales Agreement for net proceeds of $8,597,957 after payment of commission fees of $175,468 and other related expenses of $60,465. As of December 31, 2024, the Company had $0 of common stock remaining available for sale under the ATM Sales Agreement.

On December 8, 2023, the Company entered into a Placement Agent Agreement with Aegis Capital Corp. ("Aegis"), pursuant to which Aegis acted as the Company's placement agent, on a reasonable best efforts basis, in connection with the sale by the Company of an aggregate of 2,222 shares of common stock in a public offering, which included: (i) 764 shares of common stock, and (ii) pre-funded warrants to purchase 1,458 shares of common stock. The Pre-Funded Warrants had a nominal exercise price of $0.00001. Each share of common stock was sold at an offering price of $2,250, and each Pre-Funded Warrant was sold at an offering price of $2,249.85. The Company received net proceeds of approximately $4.5 million, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On April 23, 2024, the Company entered into an underwritten Agreement with Aegis Capital Corp. ("Aegis"), pursuant to which Aegis acted as the Company's underwriter on a firm commitment basis in connection with the sale by the Company of an aggregate of 3,333 shares of common stock in a public offering, which included: (i) 1,320 shares of common stock, and (ii) pre-funded warrants to purchase 2,013 shares of common stock. The Pre-Funded Warrants had a nominal exercise price of $0.0015. Each share of common stock was sold at an offering price of $1,500, and each Pre-Funded Warrant was sold at an offering price of $1,499.85. The Pre-Funded Warrants are classified as a component of permanent stockholders' equity within additional paid-in capital and were recorded at the issuance date concluding the purchase price approximated the fair value. The offering closed on April 25, 2024. On May 3 2024, the Company closed on the sale of an additional 136 shares of common stock, upon exercise by the underwriter of the over-allotment option. The Company received net proceeds of approximately $4.6 million, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On November 12, 2024, the Company entered into a securities purchase agreement with certain investors pursuant to which we sold, in a private placement, senior notes with an aggregate principal amount of $4,375,000 (the "Notes"), and received proceeds before expenses of $3,500,000. As consideration for entering into the agreement, we issued a total of 2,701 shares of common stock of the Company to the Purchasers on November 13, 2024. The principal amount of the Notes were repaid on December 23, 2024.

On November 12, 2024, the Company implemented a cost reduction plan in order to reduce its average monthly cash burn from approximately $1.8 million per month to approximately $1 million per month for 90 days. This included reducing staff from approximately 80 people to approximately 60 people, temporarily suspending certain non-essential operations and reducing or eliminating all discretionary expenses. With the additional capital raised in December 2024, the Company has resumed normal operations.

On December 20, 2024, the Company entered into a securities purchase agreement for the sale and issuance of (i) 20,507 units at a public offering price per Unit of $241.50 with each Unit consisting of one share of common stock, par value $0.00001 per share, one Series A warrant to purchase one share of Common Stock at an exercise price of $301.875 per share and one Series B warrant to purchase one share of Common Stock at an exercise price of $301.875 and (ii) 62,309 pre-funded units at a public offering price of $241.485 per Pre-Funded Unit, with each Pre-Funded Unit consisting of one pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.015 per share, one Series A Warrant and one Series B Warrant. The net proceeds to the Company from the Offering were approximately $18.2 million, after deducting placement agent's fees and the payment of other offering expenses associated with the offering that were payable by the Company.

On December 30, 2024, the "Company entered into a securities purchase agreement pursuant to which the Company agreed to sell and issue, in a registered direct offering, 44,333 shares of its common stock, par value $0.015 per share at a purchase price of $90 per share and 55,667 pre-funded warrants to purchase shares of Common Stock, at a purchase price of $89.985 per Pre-Funded Warrant. The Company received net proceeds of approximately $8.1 million from the Offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On June 26, 2025, the Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering, 192,496 shares of its common stock, par value $0.00001 per share, at a purchase price of $5.01 per share and 2,801,516 pre-funded warrants to purchase shares of common stock, at a purchase price of $5.00999 per pre-funded warrant. The Company received net proceeds of approximately $12.7 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

On June 27, 2025, the Company entered into a securities purchase agreement with certain investors, pursuant to which the Company agreed to sell and issue, in a registered direct offering, 313,564 shares of its common stock, par value $0.00001 per share, at a purchase price of $7.50 per share and 1,979,769 pre-funded warrants to purchase shares of common stock, at a purchase price of $7.49999 per pre-funded warrant. The Company received net proceeds of approximately $14.7 million from the offering, after deducting the estimated offering expenses payable by the Company, including the placement agent fees.

The Company's liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity interest investors and borrow funds to fund its general operations, research and development activities and capital expenditures. The Company's ability to continue as a going concern is dependent on management's ability to successfully execute its business plan, which includes increasing revenue while controlling operating costs and expenses and obtaining funds from outside sources of financing to generate positive financing cash flows.

Based on cash flow projections from operating and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the Company has sufficient funds for sustainable operations, and it will be able to meet its payment obligations from operations and related commitments for the 12 months following the date that these condensed consolidated financial statements were issued. Based on the above considerations, the Company's condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and liquidation of liabilities during the normal course of operations.

*<u>Cash Flows</u>*

*Operating activities*

Net cash used in operating activities for the six months ended June 30, 2025 was approximately $12.8 million, an increase of approximately $2.6 million or 25.5% compared to approximately $10.2 million for the six months ended June 30, 2024. The increase is primarily attributed to an increase in prepaid inventory for tuggers, an increase in inventory related to tuggers, and the security deposit for the new office location.

*Investing activities*

Net cash used in investing activities for the six months ended June 30, 2025 was approximately $9.1 million, a decrease of approximately $12.1 million compared to net cash provided by investing activities of approximately $3.0 million for the six months ended June 30, 2024. The decrease consists of short-term investment purchases of approximately $23.8 million and acquisition of intangible assets of $1.2 million, offset by $12.6 million in short-term investment proceeds and a decrease in equipment purchases of $0.3 million.

*Financing activities*

Net cash provided by financing activities for the six months ended June 30, 2025 was $29.6 million, which consisted of proceeds from the sale of common stock, an increase of approximately $20.0 million compared to $9.6 million for the six months ended June 30, 2024, which consisted of proceeds from at-the-market equity financing and the sale of common stock.

**Emerging Growth Company Status**

We are an "emerging-growth company", as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including, but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As an emerging growth company we can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend to avail ourselves of these options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging growth company.

We will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of the initial public offering; (ii) the first fiscal year after our annual gross revenue are $1.07 billion or more; (iii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. If, as a result of our decision to reduce future disclosure, investors find our common shares less attractive, there may be a less active trading market for our common shares and the price of our common shares may be more volatile.

We are also a "smaller reporting company", meaning that the market value of our stock held by non-affiliates plus the aggregate amount of gross proceeds to us as a result of the IPO is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

As a "Smaller Reporting Company", this Item and the related disclosure is not required.

**ITEM 4. CONTROLS AND PROCEDURES**

***Management's Report on Disclosure Controls and Procedures***

Our management, under the supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Financial Officer (our Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of June 30, 2025, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures are effective, except as described below.

***Changes in Internal Control over Financial Reporting***

As reported in our Annual Report on Form 10-K as of December 31, 2024, the following was identified as a material weakness during the fourth quarter of 2024: ineffective oversight of third parties engaged to assist in the Company's financial reporting process. During the first quarter of 2025, the material weakness persisted. Management has revised the processes surrounding this material weakness, and while a new control has been implemented, no relevant transactions occurred during the second quarter of 2025. Thus, the effectiveness of the new control could not be tested and the material weakness remains unremediated as of June 30, 2025. Notwithstanding this material weakness, management believes that the condensed consolidated financial statements included in this report fairly present, in all material respects, the Company's financial position, results of operations and cash flows for the periods presented in conformity with U.S. GAAP.

The SEC defines 'material weakness' as a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant's annual or interim financial statements will not be prevented or detected on a timely basis by the company's internal controls. While we are in the process of adopting remediation procedures related to this identified material weakness, there can be no assurance that such remedies will be effective. In addition, if this is not remediated, we will be unable to certify that our internal control over financial reporting is effective. We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations. If we are unable to conclude that our internal control over financial reporting is effective, we could lose investor confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.

Except as described as above, there has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

**PART II — OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

We are not currently a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.

**ITEM 1A. RISK FACTORS**

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in "Part I, Item 1A. Risk Factors" in the Form 10-K. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report, there were no material changes to the risks and uncertainties described in the section titled "Risk Factors" in the Form 10-K during the three months ended June 30, 2025.

**ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

None.

**ITEM 3. DEFAULTS UPON SENIOR SECURITIES**

None.

**ITEM 4. MINE SAFETY DISCLOSURES**

Not applicable.

**ITEM 5. OTHER INFORMATION**

**Rule 10b5-1 Trading Arrangement**

During the three months ended June 30, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 4.1 | [Form of Pre-Funded Warrant incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the SEC on June 27, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex4-1_cyngn.htm) |
| 4.2 | [Form of Pre-Funded Warrant incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the SEC on June 30, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex4-1_cyngn.htm) |
| 10.1 | [Form of Securities Purchase Agreement by and between the Company and the Purchasers incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on June 27, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex10-1_cyngn.htm) |
| 10.2 | [Placement Agent Agreement between the Company and Aegis Capital Corp. dated June 26, 2025 incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on June 27, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000117494725000969/ea024724801ex10-2_cyngn.htm) |
| 10.3 | [Form of Securities Purchase Agreement by and between the Company and the Purchasers incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on June 30, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex10-1_cyngn.htm) |
| 10.4 | [Placement Agent Agreement between the Company and Aegis Capital Corp. dated June 26, 2025 incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on June 30, 2025](http://www.sec.gov/Archives/edgar/data/1874097/000121390025059644/ea024742301ex10-2_cyngn.htm) |
| 31.1\* | [Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.](ea025010001ex31-1_cyngn.htm) |
| 31.2\* | [Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.](ea025010001ex31-2_cyngn.htm) |
| 32.1\*\* | [Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) or 15d-14(b) of the Securities Exchange Act, as amended, and 18 U.S.C. Section 1350.](ea025010001ex32-1_cyngn.htm) |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* Filed herewith. <br> \*\* Furnished herewith.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on this 7<sup>th</sup> day of August, 2025.

---

| |
|:---|
| **CYNGN INC.** |
| */s/ Lior Tal* |
| Lior Tal |
| Chief Executive Officer, |
| Chairman of the Board of Directors and Director |
| (Principal Executive Officer) |
| /s/ *Natalie Russell* |
| Natalie Russell |
| Interim Chief Financial Officer |
| (Principal Financial and Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO RULES 13A-14 AND 15D-14**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

I, Lior Tal, certify that:

1) I have reviewed this quarterly report on Form 10-Q of Cyngn Inc.;

2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3) Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4) The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this quarterly report is being prepared.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based
on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed
in this quarterly report any changes in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and

5) The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

---

| | |
|:---|:---|
| Date: August 7, 2025 |  |
|  | */s/ Lior Tal* |
|  | Lior Tal |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

 **CERTIFICATIONS OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO RULES 13A-14 AND 15D-14**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

I, Natalie Russell, certify that:

1) I have reviewed this quarterly report on Form 10-Q of Cyngn Inc.;

2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3) Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4) The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this quarterly report is being prepared.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Evaluated
the effectiveness of the registrant's disclosure controls and procedures and presented in this quarterly report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based
on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disclosed
in this quarterly report any changes in the registrant's internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal
control over financial reporting; and

5) The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal
control over financial reporting.

---

| | |
|:---|:---|
| Date: August 7, 2025 |  |
|  | /s/ *Natalie Russell* |
|  | Natalie Russell |
|  | Interim Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

 **CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Cyngn Inc. ("Company") on Form 10-Q for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on the date hereof ("Report"), the undersigned, in the capacities and on the date indicated below, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the knowledge of each of the undersigned:

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Date: August 7, 2025 |  |
|  | */s/ Lior Tal* |
|  | Lior Tal |
|  | Chief Executive Officer |
|  | (Principal Executive Officer) |
|  | */s/ Natalie Russell* |
|  | Natalie Russell |
|  | Interim Chief Financial Officer |
|  | (Principal Financial and Accounting Officer) |

---